Navigation Links
Major aspergillus genomics supplement published by journal Fungal Genetics and Biology
Date:4/2/2009

Amsterdam, 2 April 2009 A major effort from within the Aspergillus community has resulted in the publication of an exceptional supplement by the Elsevier journal Fungal Genetics and Biology (www.elsevier.com/locate/yfgbi). The supplement provides extensive studies based on the genome analysis of two Aspergillus species: Aspergillus niger and Aspergillus nidulans. The publication was enabled by Eurofungbase, a coordination action programme funded by the European Commission, and was strongly supported by DSM.

Aspergillus species are widely exploited by the fermentation industry for the production of foodstuffs, enzymes and organic acids. Others have been object of study for many years because of their use in the development of medications to treat human and animal infections.

Prof. Neil Gow, Editor-in-Chief of Fungal Genetics and Biology, commented: "The vast amount of data that is captured in the Aspergillus supplement will support fungal biologists around the globe and help to inform those whose work is dedicated to fighting fungal infections."

The large scale A. nidulans and A. niger annotation projects that are the basis of the publication, base their success on combining the strengths of different expert groups. Dr. Jaap Visser, one of the Guest Editors and main driver behind the project, noted: "Besides mobilizing the Aspergillus community, this meant preparing and developing an outstanding infrastructure that would enable such a large annotation effort to be effective."

The publication aims to stimulate research on A. nidulans and A. niger in order to increase knowledge of these organisms and their application on key issues of today's world: health, environment and food. The supplement provides an invaluable resource not just for scientists studying Aspergillus, but for a large community of fungal biologists and medical researchers worldwide.


'/>"/>

Contact: Alina Helsloot
a.helsloot@elsevier.com
31-204-853-835
Elsevier
Source:Eurekalert

Page: 1

Related biology news :

1. Source of major health benefits in olive oil revealed
2. A missing enzyme conveys major heart protection in pre-clinical work
3. Major NSF grant boosts UNH research on hormonal genomics
4. Rising sea levels set to have major impacts around the world
5. Cellulosic biofuel technology will generate low-cost green fuel, says major study
6. La Jolla Institute signs exclusive license agreement with Medimmune on major asthma discovery
7. NJIT to host major biomedical engineering showcase and career fair
8. Major step for drug discovery and diagnostics
9. Forsyth scientist receives major grant to support rapid, accurate, affordable test for tuberculosis
10. Foretelling a major meltdown
11. Major conference on food Dec. 1-2, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... N.C. -- When we want to listen carefully to ... The second thing we do is stop moving altogether. ... sounds generated by our own movements. , This interplay ... in the brain. Indeed, indirect evidence has long suggested ... influences the auditory cortex, which gives rise to our ...
(Date:8/27/2014)... CHICAGO , Aug. 27, 2014 /PRNewswire-iReach/ -- The ... hosting the 36 th Annual International Conference (EMBC,14), ... and Towers in Chicago, Illinois , ... than 2,500 global leaders, students, and industry professionals in ... Logo - http://photos.prnewswire.com/prnh/20140827/140333 ...
(Date:8/27/2014)... Ebola is a rare, but deadly disease that exists ... One of the most lethal strains is the Sudan ... Africa, SUDV has caused widespread illness, even as recently ... journal ACS Chemical Biology , researchers now report ... infected with SUDV. , John Dye, Sachdev Sidhu, Jonathan ...
Breaking Biology News(10 mins):Stop and listen: Study shows how movement affects hearing 2Stop and listen: Study shows how movement affects hearing 3Global Leaders In Science, Medicine, And Engineering Gather For The 36th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society, August 26-30 In Chicago 2Global Leaders In Science, Medicine, And Engineering Gather For The 36th Annual International Conference Of The IEEE Engineering In Medicine And Biology Society, August 26-30 In Chicago 3Potential therapy for the Sudan strain of Ebola could help contain some future outbreaks 2
... at the University of British Columbia have been able ... much touted antioxidant benefits, tracing valuable compounds to the ... Prof. David Kitts found that the prevailing antioxidants present ... green beans being browned under high temperatures. ...
... PORTLAND, Ore. February 1, 2011. Fact: The ... temperature of the nest: warm nests produce females, cooler nests, ... for about 220 million years, scientists now report that almost ... working to understand how global warming may affect turtle reproduction. ...
... dementia is caused by a breakdown of nerve cells ... (fronto-temporal lobe), which leads to, among other symptoms, a ... forms of frontotemporal dementia is a genetically determined reduction ... Anja Capell and Prof. Christian Haass have now shown ...
Cached Biology News:Roasting coffee beans a dark brown produces valued antioxidants: UBC food scientists 2Turtle populations affected by climate, habitat loss and overexploitation 2Malaria medication may help against 1 type of frontotemporal dementia 2
(Date:8/27/2014)... , Aug. 27, 2014 Tris Pharma, ... delivery technologies, today announced that it has been selected ... & Industry Association,s 2014 Awards for Excellence ... by an independent panel of judges from SCORE (Counselors ... Award winners will be honored at a gala event ...
(Date:8/27/2014)... 27, 2014 After the boom of ... the next beverage craze is going to be the ... formulators can use Stress Relief energy pattern which can ... making of a beverage, including minerals, herbs and liquids. ... channeling that power into rapid recovery and helping to ...
(Date:8/27/2014)... NJ (PRWEB) August 27, 2014 WriteResult, ... services – has once again shown superiority when it ... sponsor by completing the ePRO portion of their most ... The Japan-based pharma chose WriteResult’s digital writing platform ... trials – the first to complete drew data from ...
(Date:8/26/2014)... , Aug. 26, 2014  NeuroSigma, Inc., a ... established to develop bioelectronic technologies, today announced that it ... the U.S. Securities and Exchange Commission relating to a ... number of shares to be offered and the price ... determined. Jefferies LLC will act as the ...
Breaking Biology Technology:Tris Pharma Selected as an award winner in the New Jersey Business & Industry Association's 2014 Awards for Excellence 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 2Stress Relief: 1 Way to De-Stress Your Beverage Formula 3Stress Relief: 1 Way to De-Stress Your Beverage Formula 4A Perfect Record: WriteResult Maintains a 100% On-Time ePRO Record with Latest Irritable Bowel (IBS) Study Data Lock 2
... Human Genome Sciences, Inc. (Nasdaq: HGSI ... ) has initiated a Phase 3 clinical trial program ... Syncria (R) (albiglutide) in the long-term treatment of type ... receive a $9 million milestone payment in the first ...
... Inc., a technology leader in developing novel chip-on-catheter digital ... new 510(k) clearance for its Third Eye(R) Retroscope(R) (Third ... and pre-cancerous polyps in the colon. This is ... FDA to enhance polyp detection when used in conjunction ...
... www.WhatWillYourPlanBe.com offers post college-aged women expert guidance in ... 17 Many young women enter the "real ... plan, particularly when it comes to their careers, ... that the unexpected often happens -- a looming ...
Cached Biology Technology:Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes 2Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes 3Human Genome Sciences to Receive $9 Million Milestone Payment Related to GlaxoSmithKline Initiation of Phase 3 Clinical Trial of Syncria(R) in Type 2 Diabetes 4Avantis Medical Systems Announces FDA 510(k) Clearance for the Third Eye(R) Retroscope(R) for Improved Polyp Detection in the Colon 2Avantis Medical Systems Announces FDA 510(k) Clearance for the Third Eye(R) Retroscope(R) for Improved Polyp Detection in the Colon 3Avantis Medical Systems Announces FDA 510(k) Clearance for the Third Eye(R) Retroscope(R) for Improved Polyp Detection in the Colon 4Helping Young Women Succeed in Today's Unpredictable World 2Helping Young Women Succeed in Today's Unpredictable World 3Helping Young Women Succeed in Today's Unpredictable World 4
MAb to Catenin beta, N-terminal (exon 2) Catenin, beta, N-terminal (exon 2)...
Anti-CaM kinase II recognizes the enzymes a subunit (6) and reacts with tissue from all mammalian species tested, as well as with chicken and frog tissues....
Anti-Src-Like Adaptor Protein-2 AVOID FREEZE/THAW CYCLES. Recognizes the ~25 and ~28 kDa forms SLAP-2....
... media for spontaneous ligand immobilization can be coupled ... antigen, or receptor to create an affinity matrix ... couple ligands via primary amines. Affi-Gel 10 gel ... 6.5 to 11; Affi-Gel 15 gel couples acidic ...
Biology Products: